Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
terguride
Description:
A pharmaceutical compound that acts as a partial dopamine receptor agonist and is studied for endocrine, neurological, and cardiovascular conditions.
Related topics:
Neurotransmitter Receptor Influence on Behavior (19%),
Pituitary Gland Disorders and Treatments (12%),
Parkinson's Disease Mechanisms and Treatments (9%),
Receptor Mechanisms and Signaling (8%)
Wikidata ID:
wiki/Q7702355
OpenAlex ID:
keywords/terguride
Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes
2002
·
Mark J. Millan
, Lisa Maiofiss
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
534
Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes
2002
·
Adrian Newman-Tancredi
, Didier Cussac
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
213
Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. II. Agonist and Antagonist Properties at Subtypes of Dopamine D2-Like Receptor and α1/α2-Adrenoceptor
2002
·
Adrian Newman-Tancredi
, Didier Cussac
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
202
Buprenorphine and a CRF1 Antagonist Block the Acquisition of Opiate Withdrawal-Induced Conditioned Place Aversion in Rats
2004
·
Luis Stinus
, Martine Cador
, et al.
·
Neuropsychopharmacology
·
151
Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats
2010
·
R. Dumitrascu
, C. Kulcke
, et al.
·
European Respiratory Journal
·
122
PDF
5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure
2015
·
Wiebke Janssen
, Yves Schymura
, et al.
·
BioMed Research International
·
108
PDF
Agonism at 5-HT2B receptors is not a class effect of the ergolines
2005
·
Sven Jähnichen
, Reinhard Horowski
, et al.
·
European Journal of Pharmacology
·
106
Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities.
1992
·
R A Lahti
, L M Figur
, et al.
·
Molecular Pharmacology
·
98
Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention
2010
·
M. Konigshoff
, R. Dumitrascu
, et al.
·
Thorax
·
94
PDF
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic
2005
·
Yoshihiro Tadori
, Takashi Miwa
, et al.
·
European Journal of Pharmacology
·
92
Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-dopa in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
1991
·
B Gomez-Mancilla
, P J Bédard
·
Journal of Pharmacology and Experimental Therapeutics
·
81
Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors
2008
·
Yoshihiro Tadori
, Robert A. Forbes
, et al.
·
European Journal of Pharmacology
·
75
Dopamine Partial Agonist Reverses Amphetamine Withdrawal in Rats
2001
·
C Orsini
, G F Koob
, et al.
·
Neuropsychopharmacology
·
67
Dopamine agonists in schizophrenia: a review
1995
·
O Benkert
, F Müller-Siecheneder
, et al.
·
European Neuropsychopharmacology
·
64
[35S]Guanosine-5′-O-(3-thio)triphosphate Binding as a Measure of Efficacy at Human Recombinant Dopamine D4.4Receptors: Actions of Antiparkinsonian and Antipsychotic Agents
1997
·
A. Newman-Tancredi
, V. Audinot
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
55
Characterization of the Effects of the Partial Dopamine Agonist Terguride on Cocaine Self-Administration in the Rat
1998
·
Luigi Pulvirenti
, Claudia Balducci
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
52
Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action
2009
·
Felice Iasevoli
, Carmine Tomasetti
, et al.
·
Progress in Neuro-Psychopharmacology and Biological Psychiatry
·
49
Long-term serotonin effects in the rat are prevented by terguride
2007
·
Øyvind Hauso
, Björn I. Gustafsson
, et al.
·
Regulatory Peptides
·
48
A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule
2001
·
Emanuela Izzo
, Cristina Orsini
, et al.
·
Pharmacology Biochemistry and Behavior
·
48
The Effect of the Partial Dopamine Agonist Terguride on Negative Symptoms in Schizophrenics
1988
·
R. Olbrich
, H. Schanz
·
Pharmacopsychiatry
·
47
Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats.
1993
·
P M Callahan
, K A Cunningham
·
Journal of Pharmacology and Experimental Therapeutics
·
46
Behavioural profile of partial D2 dopamine receptor agonists: 1. Atypical inhibition ofd-amphetamine-induced locomotor hyperactivity and stereotypy
1991
·
David Clark
, Lesley J. Furmidge
, et al.
·
Psychopharmacology
·
45
Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors: A behavioral, biochemical and electrophysiological study
1991
·
Kjell Svensson
, Agneta Ekman
, et al.
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
45
Proof-Of-Concept Study To Investigate The Efficacy, Hemodynamics And Tolerability Of Terguride Vs. Placebo In Subjects With Pulmonary Arterial Hypertension: Results Of A Double Blind, Randomised, Prospective Phase IIa Study
2012
·
Hossein A. Ghofrani
, Hikmet Al-Hiti
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
43
Pergolide, Terguride and N,N'-spacer-linked Oligomers of Both Interact with 5-HT2A Receptors of Rat Tail Artery.
2004
·
V Křen
, E Eich
, et al.
·
Physiological Research
·
43
PDF
Show more works
View as search
Works count:
248
Citation count:
4,347
Year
Topic
Type